Weihai Baihe Biology Technological Co., Ltd. (SHA:603102)

SHA:603102 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1,127	1,135	1,135	1,136	1,100	414.17
Short-Term Investments	50.4	10.05	-	-	-	-
Cash & Short-Term Investments	1,178	1,145	1,135	1,136	1,100	414.17
Cash Growth	-0.29%	0.95%	-0.09%	3.27%	165.51%	7.66%
Accounts Receivable	124.24	122.06	83.59	54.05	47.05	34.63
Other Receivables	0.82	1.75	1.05	1.25	5.83	1.48
Receivables	125.06	123.8	84.63	55.3	52.88	36.12
Inventory	141.09	142.56	115.12	124.61	147.08	111.7
Prepaid Expenses	0.25	0.15	-	-	-	-
Other Current Assets	16.76	7.83	19.38	10.49	7.82	5.25
Total Current Assets	1,461	1,420	1,354	1,326	1,307	567.25
Property, Plant & Equipment	433.61	438.04	400.25	353.48	315.85	311.89
Goodwill	33.68	35.12	0.52	0.52	0.52	0.52
Other Intangible Assets	51.11	52.44	49.3	44.74	27.15	22.41
Long-Term Deferred Tax Assets	4.71	3.95	1.64	1.97	1.89	1.64
Long-Term Deferred Charges	1.18	1.32	0.83	-	-	-
Other Long-Term Assets	7.25	4.87	9.45	9.44	9.12	12.2
Total Assets	1,992	1,956	1,816	1,736	1,662	915.92

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	94.74	108.66	96.06	92.47	82.34	72.04
Accrued Expenses	16.31	17.82	17.18	18.87	18.49	14.95
Current Portion of Leases	4.99	3.79	0.15	1.95	0.62	1.14
Current Income Taxes Payable	16.14	20.05	4.4	5.43	4.42	0.44
Current Unearned Revenue	50.77	56.93	42.25	45.35	68.72	41.41
Other Current Liabilities	29.1	33.02	33.04	39.53	42.49	48.47
Total Current Liabilities	212.06	240.26	193.08	203.6	217.09	178.45
Long-Term Leases	15.23	10.57	0.05	-	1.95	2.32
Long-Term Unearned Revenue	12.54	13.91	16.68	18.1	20.9	21.43
Other Long-Term Liabilities	4.75	4.75	-	-	-	-
Total Liabilities	244.57	269.48	209.81	221.7	239.93	202.2

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	64	64	64	64	64	48
Additional Paid-In Capital	654.95	654.95	654.95	654.95	654.95	68.46
Retained Earnings	1,070	1,008	925.84	833.77	703.1	597.26
Treasury Stock	-68.88	-68.88	-38.86	-38.25	-	-
Comprehensive Income & Other	-6.06	-2.2	-	-	-	-
Total Common Equity	1,714	1,655	1,606	1,514	1,422	713.72
Minority Interest	34.17	30.6	-	-	-	-
Shareholders' Equity	1,748	1,686	1,606	1,514	1,422	713.72
Total Liabilities & Equity	1,992	1,956	1,816	1,736	1,662	915.92

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	20.22	14.36	0.2	1.95	2.57	3.46
Net Cash (Debt)	1,157	1,131	1,134	1,134	1,097	410.71
Net Cash Growth	-1.38%	-0.29%	0.07%	3.33%	167.12%	6.76%
Net Cash Per Share	18.79	18.05	17.75	17.70	17.51	8.54
Filing Date Shares Outstanding	62.27	62.27	62.89	62.98	64	48
Total Common Shares Outstanding	62.27	62.27	62.98	63	64	48
Working Capital	1,249	1,180	1,161	1,122	1,090	388.8
Book Value Per Share	27.52	26.58	25.50	24.04	22.22	14.87
Tangible Book Value	1,629	1,568	1,556	1,469	1,394	690.79
Tangible Book Value Per Share	26.16	25.18	24.71	23.32	21.79	14.39
Buildings	329.46	324.5	252.67	228.89	207.62	204.83
Machinery	351.74	347.06	312.52	273.45	241.23	215.17
Construction In Progress	0.54	1.5	52.68	30.7	17.07	14.56

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error